SAN JOSE, Calif., Sept. 8, 2019 /PRNewswire/ — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and …
Home Investments Aridis Pharmaceuticals to Present at the HC Wainwright 21st Annual Global Investment...










